FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2114365221> ?p ?o ?g. }

• W2114365221 endingPage "31" @default.
• W2114365221 startingPage "24" @default.
• W2114365221 abstract "Sex differences in the epidemiology and clinical management of AF are evident. Of note, females are more symptomatic and if age >65, are at higher risk of thromboembolism if incident AF develops, compared with males.In an analysis from the dataset of the Euro Observational Research Programme on Atrial Fibrillation (EORP-AF) Pilot survey (n = 3119), we examined sex-related differences in presentation, treatment, and outcome of contemporary patients with AF in Europe.Female subjects were older (P < 0.0001), with a greater proportion aged ≥75 years, with more heart failure and hypertension. Heart failure with preserved ejection fraction was more common in females (P < 0.0001), as was valvular heart disease (P = 0.0003). Females were more symptomatic compared with males with a higher proportion being EHRA Class III and IV (P = 0.0012). The more common symptoms that were more prevalent in females were palpitations (P < 0.0001) and fear/anxiety (P = 0.0007). Other symptoms (e.g. dyspnoea, chest pain, fatigue, etc.) were not different between males and females. Health status scores were significantly lower for females overall, specifically for the psychological and physical domains (both P < 0.0001) but not for the sexual activity domain (P = 0.9023). Females were less likely to have electrical cardioversion (18.9 vs. 25.5%, P < 0.0001), and more likely to receive rate control (P = 0.002). Among patients recruited in hospital and discharged alive (n = 2009), documented contraindications to vitamin K antagonist (VKA) were evident in 23.8% of females. A CHA2DS2-VASc score ≥2 was found in 94.7% of females and 74.6% of males (P < 0.0001), with oral anticoagulants being used in 95.3 and 76.2%, respectively (P < 0.0001). A HAS-BLED score of ≥3 was found in 12.2% of females and 14.5% of males. Independent predictors of VKA use in females on multivariate analysis were CHA2DS2-VASc score (P = 0.0007), lower HAS-BLED score (P = 0.0284), and prosthetic mechanical valves (P = 0.0276).The EORP-AF Pilot survey provides contemporary data on sex differences in clinical features and management of AF patients participating in the EORP-AF Pilot registry. Female subjects were older and more symptomatic, compared with males, and were more likely to receive rate control. Also, female patients were at higher stroke risk overall, but oral anticoagulation was used in a high proportion of patients." @default.
• W2114365221 created "2016-06-24" @default.
• W2114365221 creator A5004850283 @default.
• W2114365221 creator A5018709534 @default.
• W2114365221 creator A5029606867 @default.
• W2114365221 creator A5032042351 @default.
• W2114365221 creator A5038405190 @default.
• W2114365221 creator A5041486249 @default.
• W2114365221 creator A5048738698 @default.
• W2114365221 creator A5058415494 @default.
• W2114365221 creator A5066283101 @default.
• W2114365221 creator A5076713156 @default.
• W2114365221 creator A5078458093 @default.
• W2114365221 creator A5087591276 @default.
• W2114365221 creator A5088052212 @default.
• W2114365221 creator A5088186128 @default.
• W2114365221 date "2014-06-23" @default.
• W2114365221 modified "2023-10-18" @default.
• W2114365221 title "Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation" @default.
• W2114365221 cites W126216541 @default.
• W2114365221 cites W1963810099 @default.
• W2114365221 cites W1976210867 @default.
• W2114365221 cites W2013217234 @default.
• W2114365221 cites W2023143117 @default.
• W2114365221 cites W2027607489 @default.
• W2114365221 cites W2028933957 @default.
• W2114365221 cites W2051565963 @default.
• W2114365221 cites W2066098573 @default.
• W2114365221 cites W2089222520 @default.
• W2114365221 cites W2092504136 @default.
• W2114365221 cites W2114112775 @default.
• W2114365221 cites W2128413398 @default.
• W2114365221 cites W2154464108 @default.
• W2114365221 cites W2155301214 @default.
• W2114365221 cites W2159975225 @default.
• W2114365221 cites W2171868042 @default.
• W2114365221 cites W35889501 @default.
• W2114365221 cites W4297900745 @default.
• W2114365221 doi "https://doi.org/10.1093/europace/euu155" @default.
• W2114365221 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24957921" @default.
• W2114365221 hasPublicationYear "2014" @default.
• W2114365221 type Work @default.
• W2114365221 sameAs 2114365221 @default.
• W2114365221 citedByCount "146" @default.
• W2114365221 countsByYear W21143652212014 @default.
• W2114365221 countsByYear W21143652212015 @default.
• W2114365221 countsByYear W21143652212016 @default.
• W2114365221 countsByYear W21143652212017 @default.
• W2114365221 countsByYear W21143652212018 @default.
• W2114365221 countsByYear W21143652212019 @default.
• W2114365221 countsByYear W21143652212020 @default.
• W2114365221 countsByYear W21143652212021 @default.
• W2114365221 countsByYear W21143652212022 @default.
• W2114365221 countsByYear W21143652212023 @default.
• W2114365221 crossrefType "journal-article" @default.
• W2114365221 hasAuthorship W2114365221A5004850283 @default.
• W2114365221 hasAuthorship W2114365221A5018709534 @default.
• W2114365221 hasAuthorship W2114365221A5029606867 @default.
• W2114365221 hasAuthorship W2114365221A5032042351 @default.
• W2114365221 hasAuthorship W2114365221A5038405190 @default.
• W2114365221 hasAuthorship W2114365221A5041486249 @default.
• W2114365221 hasAuthorship W2114365221A5048738698 @default.
• W2114365221 hasAuthorship W2114365221A5058415494 @default.
• W2114365221 hasAuthorship W2114365221A5066283101 @default.
• W2114365221 hasAuthorship W2114365221A5076713156 @default.
• W2114365221 hasAuthorship W2114365221A5078458093 @default.
• W2114365221 hasAuthorship W2114365221A5087591276 @default.
• W2114365221 hasAuthorship W2114365221A5088052212 @default.
• W2114365221 hasAuthorship W2114365221A5088186128 @default.
• W2114365221 hasBestOaLocation W21143652211 @default.
• W2114365221 hasConcept C107130276 @default.
• W2114365221 hasConcept C126322002 @default.
• W2114365221 hasConcept C164705383 @default.
• W2114365221 hasConcept C23131810 @default.
• W2114365221 hasConcept C2776403943 @default.
• W2114365221 hasConcept C2777289489 @default.
• W2114365221 hasConcept C2778198053 @default.
• W2114365221 hasConcept C2778704086 @default.
• W2114365221 hasConcept C2779161974 @default.
• W2114365221 hasConcept C2779736815 @default.
• W2114365221 hasConcept C71924100 @default.
• W2114365221 hasConcept C78085059 @default.
• W2114365221 hasConceptScore W2114365221C107130276 @default.
• W2114365221 hasConceptScore W2114365221C126322002 @default.
• W2114365221 hasConceptScore W2114365221C164705383 @default.
• W2114365221 hasConceptScore W2114365221C23131810 @default.
• W2114365221 hasConceptScore W2114365221C2776403943 @default.
• W2114365221 hasConceptScore W2114365221C2777289489 @default.
• W2114365221 hasConceptScore W2114365221C2778198053 @default.
• W2114365221 hasConceptScore W2114365221C2778704086 @default.
• W2114365221 hasConceptScore W2114365221C2779161974 @default.
• W2114365221 hasConceptScore W2114365221C2779736815 @default.
• W2114365221 hasConceptScore W2114365221C71924100 @default.
• W2114365221 hasConceptScore W2114365221C78085059 @default.
• W2114365221 hasIssue "1" @default.
• W2114365221 hasLocation W21143652211 @default.
• W2114365221 hasLocation W21143652212 @default.
• W2114365221 hasOpenAccess W2114365221 @default.

• next